These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1620197)

  • 1. Measures of pregnant, drug-abusing women for treatment research.
    Selden AM
    NIDA Res Monogr; 1992; 117():194-211. PubMed ID: 1620197
    [No Abstract]   [Full Text] [Related]  

  • 2. Issues in subject recruitment and retention with pregnant and parenting substance-abusing women.
    Howard J; Beckwith L
    NIDA Res Monogr; 1996; 166():68-86. PubMed ID: 8818166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The psychosocial history: an interview for pregnant and parenting women in substance abuse treatment and research.
    Comfort M; Kaltenbach KA
    NIDA Res Monogr; 1996; 166():123-42. PubMed ID: 8818169
    [No Abstract]   [Full Text] [Related]  

  • 4. Methodological issues in prevention research on drug use and pregnancy.
    Gilchrist LD; Gillmore MR
    NIDA Res Monogr; 1992; 117():1-17. PubMed ID: 1620189
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies of prenatal drug exposure and environmental research issues: the benefits of integrating research within a treatment program.
    Kaltenbach KA; Finnegan LP
    NIDA Res Monogr; 1992; 117():259-70. PubMed ID: 1620201
    [No Abstract]   [Full Text] [Related]  

  • 6. Illicit use of clonidine in opiate-abusing pregnant women.
    Anderson F; Paluzzi P; Lee J; Huggins G; Svikis D
    Obstet Gynecol; 1997 Nov; 90(5):790-4. PubMed ID: 9351766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Process measures in interventions for drug-abusing women: from coping to competence.
    Blechman EA; Wills TA; Adler V
    NIDA Res Monogr; 1992; 117():314-43. PubMed ID: 1620205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Who is it going to be? Subject selection issues in prenatal drug exposure research.
    Fried PA
    NIDA Res Monogr; 1992; 117():121-36. PubMed ID: 1620191
    [No Abstract]   [Full Text] [Related]  

  • 9. Maternal and fetal effects from substance use.
    Rayburn WF
    Clin Perinatol; 2007 Dec; 34(4):559-71, vi. PubMed ID: 18063105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of prenatal drug exposure in the pregnant woman and her newborn infant.
    Ostrea EM
    NIDA Res Monogr; 1992; 117():61-79. PubMed ID: 1620211
    [No Abstract]   [Full Text] [Related]  

  • 11. Alcohol- and drug-dependent pregnant women: laws and public policies that promote and inhibit research and the delivery of services.
    Weber EM
    NIDA Res Monogr; 1992; 117():349-65. PubMed ID: 1620207
    [No Abstract]   [Full Text] [Related]  

  • 12. Discussion: measurement issues in the study of effects of substance abuse in pregnancy.
    Coles CD
    NIDA Res Monogr; 1992; 117():248-58. PubMed ID: 1620200
    [No Abstract]   [Full Text] [Related]  

  • 13. Recruitment and retention of adolescent women in drug treatment research.
    Palinkas LA; Atkins CJ; Noel P; Miller C
    NIDA Res Monogr; 1996; 166():87-109. PubMed ID: 8818167
    [No Abstract]   [Full Text] [Related]  

  • 14. Introduction to the Perinatal-20 treatment research demonstration program.
    Rahdert ER
    NIDA Res Monogr; 1996; 166():1-5. PubMed ID: 8818161
    [No Abstract]   [Full Text] [Related]  

  • 15. Discussion: dilemmas in research in perinatal addiction--intervention issues.
    Finnegan LP
    NIDA Res Monogr; 1992; 117():344-8. PubMed ID: 1620206
    [No Abstract]   [Full Text] [Related]  

  • 16. Subject recruitment and retention for longitudinal research: practical considerations for a nonintervention model.
    Streissguth AP; Guinta CT
    NIDA Res Monogr; 1992; 117():137-54. PubMed ID: 1620192
    [No Abstract]   [Full Text] [Related]  

  • 17. Methodological issues in obtaining and managing substance abuse information from prenatal patients.
    Sokol RJ; Ager JW; Martier SS
    NIDA Res Monogr; 1992; 117():80-97. PubMed ID: 1620212
    [No Abstract]   [Full Text] [Related]  

  • 18. Psychosocial stressors of drug-abusing disadvantaged adolescent mothers.
    Scafidi FA; Field T; Prodromidis M; Rahdert E
    Adolescence; 1997; 32(125):93-100. PubMed ID: 9105494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Building bridges: treatment research partnerships in the community.
    Chasnoff IJ; Marques PR; Strantz IH; Farrow J; Davis S
    NIDA Res Monogr; 1996; 166():6-21. PubMed ID: 8818162
    [No Abstract]   [Full Text] [Related]  

  • 20. Discussion: subject selection, recruitment, and retention in longitudinal studies involving perinatal substance abuse and human immunodeficiency virus infection.
    Bandstra ES
    NIDA Res Monogr; 1992; 117():183-93. PubMed ID: 1620196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.